Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Direct Effect Media/Illumina

Industry News

Image: The global POC coagulation testing market is projected to grow due in part by the growing geriatric population worldwide (Photo courtesy of Shutterstock).

Global POC Coag Test Market Driven by Increasing Geriatrics

The global point-of-care (POC) coagulation testing market is projected to grow at a CAGR of over 6% during the period 2018-2022, driven by the growing geriatric population, worldwide, and increasing focus on personalized medicine. These are the latest findings of Technavio Research, a global technology research and advisory company. More...
03 May 2018
Image: The global PCR market is projected to surpass USD 7.4 billion by 2025 (Photo courtesy of iStock).

Global PCR Market to Surpass USD 7 Billion by 2025

The global polymerase chain reaction market (PCR) was valued at USD 3.7 billion in 2017 and is projected to grow at a CAGR of 8.8% over the forecast period (2017 – 2025) to surpass USD 7.4 billion by 2025. The extensive applications of the PCR laboratory technique in various fields, rising prevalence and incidence of infectious and chronic diseases, and growing need to develop advanced PCR systems for the rapid and inexpensive quantitative detection of target samples are expected to be the key growth drivers of the PCR market during the forecast period. More...
03 May 2018
Image: The FastFinder software is designed to improve workflow using AI-powered automation (Photo courtesy of Siemens Healthcare).

Siemens Healthineers Launches Thermocycler with AI-Powered Software

Siemens Healthineers launched a new molecular thermocycler, the Fast Track cycler (FTC), and the complementary new FastFinder software at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2018). The compact FTC allows laboratories of all sizes to implement molecular testing with simplicity and speed, while the FastFinder software improves workflow using Artificial Intelligence (AI)-powered automation. More...
26 Apr 2018
Image: Left: Overview of the ARM. A digital camera captures the same field of view (FoV) as the user and passes the image to an attached compute unit capable of running real-time inference of a machine-learning model. The results are fed back into a custom AR display, which is inline with the ocular lens and projects the model output on the same plane as the slide. Right: A picture of the prototype, which has been retrofitted into a typical clinical-grade light microscope (Photo courtesy of Google).

Google Builds AR Microscope for Cancer Detection

A team of researchers at Google LLC has developed a prototype Augmented Reality Microscope (ARM) platform that could help accelerate and democratize the adoption of deep learning tools for pathologists around the world. The platform comprises a modified light microscope that allows for real-time image analysis and presentation of the results of machine learning algorithms directly into the field of view. The ARM can be retrofitted into existing light microscopes in hospitals and clinics using low-cost, readily available components, and without the need for analyzing whole slide digital versions of the tissue. More...
25 Apr 2018
Image: The Second Read (SR) system is designed to identify various cell types and features within whole slide images (Photo courtesy of Ibex Medical Analytics).

AI-Based Cancer Diagnosis System Eliminates Errors

The first-ever artificial intelligence (AI)-based digital pathology diagnostic system has been deployed in a live clinical setting, following a pilot period, in which the system identified isolated major errors in retrospective prostate core needle biopsies (PCNBs) that had been diagnosed as benign. More...
25 Apr 2018
Image: At ECCMID 2018, Seegene showcased its molecular diagnostic system SGSTAR, which allows order-to-report on the same day and enables the running of the combination test (Photo courtesy of Seegene).

Seegene Unveils Combination Test at ECCMID 2018

Seegene Inc., a developer of multiplex PCR technologies, introduced a combination test at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2018) held in Madrid, Spain, from April 21 to 24, 2018. The combination test is a high-efficiency solution that diagnoses various causes of diseases with multiplex molecular diagnosis assays. Seegene also showcased its molecular diagnostic system SGSTAR (Seegene Sameday Test and Report), which allows order-to-report on the same day and enables the running of the combination test. More...
19 Apr 2018
Image: The global POC blood glucose monitoring devices market is expected to reach USD 2 billion in 2022, driven mainly by public and private initiatives to reduce diabetic cases (Photo courtesy of iStock).

POC Glucose Monitoring Devices Market to Reach USD 2 Billion in 2022

The global POC blood glucose monitoring devices market is expected to reach USD 2.03 billion in 2022, driven mainly by public and private initiatives to reduce diabetic cases. However, the high cost associated with diabetes management is one of the major factors hindering the market growth. More...
04 Apr 2018


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
Copyright © 2000-2018 Globetech Media. All rights reserved.